Makeown Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-01-2025
- Paid Up Capital ₹ 1.85 Cr
as on 23-01-2025
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 23-01-2025
- Satisfied Charges ₹ 3.30 M
as on 23-01-2025
- Revenue 16.20%
(FY 2023)
- Profit 79.17%
(FY 2023)
- Ebitda 58.24%
(FY 2023)
- Net Worth 102.15%
(FY 2023)
- Total Assets 383.97%
(FY 2023)
About Makeown Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹3.30 M, as per Ministry of Corporate Affairs (MCA) records.
Pramod Bhor, Madhumita Dey, Chandrashekhar Bangar, and Six other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2013PTC250353
- Company No.
250353
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Makeown Pharma?
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Bhor  | Additional Director | 20-Jul-2015 | Current |
| Madhumita Dey | Additional Director | 20-Jul-2015 | Current |
| Chandrashekhar Bangar | Director | 25-Nov-2013 | Current |
| Manish Baranwal | Director | 25-Nov-2013 | Current |
| Anil Solanki | Additional Director | 20-Jul-2015 | Current |
| Rajeevkumar Palvia | Additional Director | 20-Jul-2015 | Current |
Financial Performance of Makeown Pharma.
Makeown Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.2% increase. The company also saw a substantial improvement in profitability, with a 79.17% increase in profit. The company's net worth Soared by an impressive increase of 102.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Makeown Pharma?
Unlock access to Makeown Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Enki Mining India Private LimitedActive 2 years 7 months
Pramod Bhor, Madhumita Dey and 2 more are mutual person
Charges (Loans)
₹0.50 Cr
₹0.33 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2016 | Yes Bank Limited | ₹5.00 M | Open |
| 29 Dec 2015 | Nkgsb Co-Operative Bank Ltd. | ₹3.30 M | Satisfied |
How Many Employees Work at Makeown Pharma?
Makeown Pharma has a workforce of 13 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Makeown Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makeown Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.